Cite
HARVARD Citation
Suzuki, R. et al. (2023). The novel sustained 3‐hydroxybutyrate donor poly‐D‐3‐hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T‐cells. FASEB journal. 37 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Suzuki, R. et al. (2023). The novel sustained 3‐hydroxybutyrate donor poly‐D‐3‐hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T‐cells. FASEB journal. 37 (1), p. n/a. [Online].